Literature DB >> 20305505

Ultrasonic bone removal versus high-speed burring for lateral orbital decompression: comparison of surgical outcomes for the treatment of thyroid eye disease.

Raymond I Cho1, Christina H Choe, Victor M Elner.   

Abstract

PURPOSE: To evaluate the efficacy of ultrasonic bone removal during lateral orbital decompression for thyroid eye disease.
METHODS: Retrospective, comparative, interventional case series of lateral orbital decompressions performed by the senior author for thyroid eye disease between July 2005 and July 2008. Patients were excluded if they had other coexisting orbital conditions or concurrent decompression of other orbital walls. Primary outcome measures included visual acuity, proptosis, lagophthalmos, eyelid retraction, and exposure keratopathy.
RESULTS: Thirty-six consecutive lateral orbital decompressions performed by the senior author were reviewed. The Sonopet Omni ultrasonic surgical aspirator was used to remove the lateral wall in 18 cases, and a high-speed drill with a cutting burr was used in the other 18 cases. There was no significant difference between the groups in postoperative visual acuity, proptosis reduction, lagophthalmos, eyelid retraction, exposure keratopathy, or surgical complications. The average reduction in proptosis was 3.9 mm (range, 1-6.5 mm) in the Sonopet group and 4.0 mm (range, 1-6 mm) in the drill group (p = 0.86). In our series, the average surgical case time was slightly shorter in the Sonopet group than in the drill group (104 vs. 118 minutes, p = 0.032).
CONCLUSIONS: Ultrasonic bone removal is a safe and effective alternative to high-speed burring during lateral orbital decompression for thyroid eye disease.

Entities:  

Mesh:

Year:  2010        PMID: 20305505     DOI: 10.1097/IOP.0b013e3181b8e614

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  8 in total

1.  Use of an ultrasonic bone curette (Sonopet) in orbital and oculoplastic surgery.

Authors:  Ivan Vrcek; Victoria Starks; Ronald Mancini; Grant Gilliland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

2.  Piezosurgery for osteotomies in orbital surgery: Our experience and review of the literature.

Authors:  Maurizio Iacoangeli; Piergiorgio Neri; Paolo Balercia; Ettore Lupi; Alessandro Di Rienzo; Niccolò Nocchi; Lorenzo Alvaro; Massimo Scerrati
Journal:  Int J Surg Case Rep       Date:  2012-11-17

3.  Novel Application of an Ultrasonic Bone Aspirator for Endoscopic Modified Medial Maxillectomy.

Authors:  Hiromasa Takakura; Hirohiko Tachino; Yutaro Oi; Tram Anh Do; Hideo Shojaku
Journal:  Front Surg       Date:  2022-06-01

4.  Endoscopic ultrasonic curette-assisted removal of frontal osteomas.

Authors:  A Bolzoni Villaret; A Schreiber; I Esposito; P Nicolai
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

5.  Endoscopic ultrasonic dacryocystorhinostomy: clinical profile and outcomes.

Authors:  Mohammad Javed Ali; Manpreet Singh; Naja Chisty; Saurabh Kamal; Milind N Naik
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-03       Impact factor: 2.503

Review 6.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

7.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27

8.  Deep Lateral Wall Partial Rim-Sparing Orbital Decompression with Ultrasonic Bone Removal for Treatment of Thyroid-Related Orbitopathy.

Authors:  Álvaro Bengoa-González; Alicia Galindo-Ferreiro; Enrique Mencía-Gutiérrez; Hortensia Sánchez-Tocino; Agustín Martín-Clavijo; María-Dolores Lago-Llinás
Journal:  J Ophthalmol       Date:  2019-12-02       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.